P1129: GLOFITAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) LARGE B-CELL LYMPHOMA (LBCL): EXTENDED FOLLOW-UP AND LANDMARK ANALYSES FROM A PIVOTAL PHASE II STUDY

• Martin Hutchings,
• Carmelo Carlo-Stella,
• Franck Morschhauser,
• Michael Dickinson,
• Emmanuel Bachy,
• Guillaume Cartron,
• Cyrus Khan,
• Monica Tani,
• Joaquín Martinez-Lopez,
• Nancy L. Bartlett,
• Antonio Salar,
• Joshua Brody,
• Sirpa Leppa,
• Pauline Baumlin,
• Linda Lundberg,
• James Relf,
• Yuying Xie,
• Alessia Bottos,
• Kathryn Humphrey,
• Lorenzo Falchi

Affiliations

Martin Hutchings

1 Rigshospitalet, Copenhagen, Denmark

Carmelo Carlo-Stella

2 Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy

Franck Morschhauser

3 Hôpital Claude Huriez and CHU de Lille, Lille, France

Michael Dickinson

4 Peter MacCallum Cancer Centre, Royal Melbourne Hospital and The University of Melbourne, Melbourne, VIC, Australia

Emmanuel Bachy

5 Centre Hospitalier Lyon-Sud, Lyon, France

Guillaume Cartron

6 CHU de Montpellier, Montpellier, France

Cyrus Khan

7 Allegheny Health Network, Pittsburgh, PA, United States

Monica Tani

8 Ospedale Santa Maria delle Croci, Ravenna, Italy

Joaquín Martinez-Lopez

9 Department of Hematology, Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center (CNIO), Complutense University Madrid, 28041 Madrid, Spain

Nancy L. Bartlett

10 Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, United States

Antonio Salar

11 Department of Hematology, Hospital del Mar, Passeig Maritim, 08003 Barcelona, Spain

Joshua Brody

12 Tisch Cancer Institute, New York, NY, United States

Sirpa Leppa

13 University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland

Pauline Baumlin

14 F. Hoffmann-La Roche Ltd, Basel, Switzerland

Linda Lundberg

14 F. Hoffmann-La Roche Ltd, Basel, Switzerland

James Relf

15 Roche Products Ltd, Welwyn Garden City, United Kingdom

Yuying Xie

16 F. Hoffmann-La Roche Ltd, Mississauga, Canada

Alessia Bottos

14 F. Hoffmann-La Roche Ltd, Basel, Switzerland

Kathryn Humphrey

15 Roche Products Ltd, Welwyn Garden City, United Kingdom

Lorenzo Falchi

17 Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, United States